drugset / Trial / NCT02759198

A Clinical Trial of YH23537 in Patients With Knee Osteoarthritis

NCT02759198

Phase 2 Completed 456 enrolled Yuhan Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate efficacy and safety of YH23537 versus celebrex in patients with knee osteoarthritis.

Timeline

Start
2016-05-02
Primary completion
2017-05-24
Completion
2017-09-26

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 200 mg
Subject YH23537 Unknown 750 mg
Subject YH23537 Unknown 1500 mg
Subject YH23537 Unknown 3000 mg

Indications